Obsessive-compulsive Disorder
📧 Sign up to get email alerts when something new happens for Obsessive-compulsive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Effects of Marijuana on Symptoms of OCD [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial explored the effects of marijuana on symptoms in obsessive-compulsive disorder; results have been poste…
-
FDA approval · 2020-06-22FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approves a generic version of clomipramine hydrochloride as an original application by Micro Labs Limited for obsessive-compulsive disor…
-
FDA approval · 2020-06-10FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved Aurobindo Pharma Limited's generic fluoxetine through an Original Application (ANDA).
-
FDA approval · 2020-05-11FDA Approved: FLUVOXAMINE MALEATE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma's original application for fluvoxamine maleate, an SSRI indicated for obsessive-compulsive disorder.
-
FDA approval · 2020-04-28FDA Approved: PROZAC — Supplemental Application (Dista Products Company)
The FDA approved a supplemental application for Prozac (fluoxetine hydrochloride) submitted by Dista Products Company.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2020-04-08FDA Approved: FLUOXETINE — Original Application (Aurobindo Pharma Limited)
FDA approved a generic fluoxetine product from Aurobindo Pharma Limited under an Original Application (ANDA 213286). Fluoxetine is an SSRI i…
-
CLINICAL_TRIALS trial_result · 2020-03-17Clinical Trial Update: Intravenous Immunoglobulin for PANDAS [Phase 3]
Phase 3 trial evaluating intravenous immunoglobulin for PANDAS in children with obsessive-compulsive disorder has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2020-02-28Clinical Trial Update: Cannabinoid Medication for Adults With OCD [Phase 1, Phase 2]
Phase 1/2 clinical trial investigating a cannabinoid medication for adults with obsessive-compulsive disorder has completed with posted resu…
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE — Supplemental Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
FDA approved a supplemental application for sertraline from Heritage Pharmaceuticals (d/b/a Avet), signaling approval of a change or additio…
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for sertraline hydrochloride (generic sertraline).
-
FDA approval · 2020-02-21FDA Approved: SERTRALINE HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for an additional generic version of sertraline hydrochloride, expanding the availability of this an…
-
FDA approval · 2020-02-07FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Original Application (Leading Pharma, LLC)
FDA approved the Original Application for clomipramine hydrochloride (generic) from Leading Pharma, LLC. The product is indicated for obsess…
-
CLINICAL_TRIALS trial_result · 2020-02-06Clinical Trial Update: Deep Brain Stimulation and Obsessive-compulsive Disorder [Phase 3]
Phase 3 clinical trial update on deep brain stimulation for obsessive-compulsive disorder has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-25Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (rTMS) for Obsessive-Compulsive Disorder (OCD) [NA]
This is a terminated clinical trial update for repetitive transcranial magnetic stimulation (rTMS) in obsessive-compulsive disorder with res…
-
FDA approval · 2019-10-29FDA Approved: FLUOXETINE — Supplemental Application (Vensun Pharmaceuticals, Inc.)
FDA approved a supplemental application for a fluoxetine hydrochloride product from Vensun Pharmaceuticals, thereby approving a generic vers…
-
CLINICAL_TRIALS trial_result · 2019-10-11Clinical Trial Update: Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder [Phase 4]
A Phase 4 clinical trial update reports on the effectiveness of deep brain stimulation for treating treatment-resistant obsessive-compulsive…
-
FDA approval · 2019-09-11FDA Approved: PAROXETINE HYDROCHLORIDE — Supplemental Application (Apotex Corp)
FDA supplemental approval granted for Apotex Corp's paroxetine hydrochloride product, approving a generic formulation under NDA 020936.
-
CLINICAL_TRIALS trial_result · 2019-09-06Clinical Trial Update: N-acetylcysteine (NAC) for Pediatric Obsessive-Compulsive Disorder [Phase 2]
Phase 2 clinical trial evaluating N-acetylcysteine for pediatric obsessive-compulsive disorder has completed with results posted.
-
CLINICAL_TRIALS research · 2019-08-28Clinical Trial Update: Transdiagnostic Psychotherapy for Veterans With Mood and Anxiety Disorders [NA]
A completed clinical trial examining transdiagnostic psychotherapy for veterans with mood and anxiety disorders, with results posted in 2019…
-
FDA approval · 2019-08-15FDA Approved: CLOMIPRAMINE HYDROCHLORIDE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for clomipramine hydrochloride capsules.
-
CLINICAL_TRIALS trial_result · 2019-06-18Clinical Trial Update: A Study of Pregabalin (Lyrica) Augmentation in Serotonin Reuptake Inhibitor-Refractory Obsessive Compulsive Disorder [Phase 4]
Phase 4 trial updating pregabalin as an augmentation in obsessive-compulsive disorder patients refractory to SSRIs has completed.
-
CLINICAL_TRIALS trial_result · 2019-06-14Clinical Trial Update: Exposure-Focused Family-Based CBT for Youth With ASD and Comorbid Anxiety [NA]
Completed clinical trial evaluating exposure-focused family-based CBT for youth with autism spectrum disorders and comorbid anxiety; results…
-
FDA approval · 2019-05-23FDA Approved: FLUOXETINE — Original Application (Cadila Pharmaceuticals Limited)
Cadila Pharmaceuticals Limited received FDA approval for an original application of fluoxetine (generic).
-
CLINICAL_TRIALS trial_result · 2019-05-10Clinical Trial Update: Memantine Treatment for Obsessive-compulsive Disorder and Generalized Anxiety Disorder [Phase 3]
Phase 3 trial evaluating memantine for obsessive-compulsive disorder and generalized anxiety disorder has completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Dealing With Intrusive Thoughts in OCD - a Comparison of Detached Mindfulness and Cognitive Restructuring [NA]
Completed clinical trial comparing Detached Mindfulness and Cognitive Restructuring for intrusive thoughts in obsessive-compulsive disorder;…